Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation
Open Access
- 1 April 2012
- journal article
- Published by Elsevier BV
- Vol. 287 (18), 14615-14620
- https://doi.org/10.1074/jbc.c112.353946
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viabilityProceedings of the National Academy of Sciences of the United States of America, 2011
- Reductive carboxylation supports growth in tumour cells with defective mitochondriaNature, 2011
- Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeProceedings of the National Academy of Sciences of the United States of America, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell LinePublished by Elsevier BV ,2008
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesisProceedings of the National Academy of Sciences of the United States of America, 2007